- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00546390
Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Purpose:
- Determine, in a pilot study, if surrogate markers of rIP can be detected in patients presenting for cardiac surgery. Specifically measure the effect of rIP on the expression profile of HSP-70, iNOS, PKC-E, p38 MAPK, PI3K, and sarcolemmal KATP
- Determine if rIP influences the expression of genes known to influence substrate preference and thereby myocardial metabolism in patients undergoing heart surgery. Specifically the expression of HIF-1a, PPAR-a and AMPK
Hypothesis:
We hypothesize that rIP provides myocardial protection in patients presenting for heart surgery and that this protection is defined by a distinct gene expression profile with regards to genes involved in rIP and myocardial metabolism.
Study Design:
This proposal is for a randomized blinded pilot study on the use of rIP in patients requiring heart surgery.
Study Population:
The study will include 100 male and female patients undergoing elective heart surgery with cardiopulmonary bypass (CPB).
Randomization:
Patients will be randomized 1:1 to receive either rIP or no treatment.
Blinding Procedures:
The patient will be blinded as well as those performing the experimental analysis.
Interventions:
Remote Ischemic Preconditioning
rIP will be induced immediately following induction of anesthesia. Four 5 minute cycles of lower unilateral limb ischemia and reperfusion induced tourniquet inflation to 300 mmHg will constitute the preconditioning stimulus.
Blood sample collection/analysis
- Two cardiac biopsies (50 - 200 mg) will be collected pre-bypass and post- bypass and will be analyzed for gene and protein expression.
- Blood samples (4 mL) will be drawn immediately before induction of anesthesia, and at the same times as cardiac tissue samples are harvested and analyzed for gene/protein expression as well as at 1, 24, 48 and 72 hours post surgery. Troponin I and NT-ProBNP will be measured at baseline, 1, 24, 48 and 72 hours after surgery and 3 mL of blood will be collected for these tests. A total of 43 mL of blood will be collected per patient.
- rIP induced changes in leukocyte gene expression will be measured at the aforementioned time points.
Other
ECG assessment on post-operative day 1, 2, and 3.
National Institute of Health stroke scale assessment will be conducted at screening and post operatively prior to hospital discharge.
Each patient will receive a telephone follow-up call at 30 days post operatively to collect adverse events and mortality data.
Experimental Methods:
- qRT-PCR will be used to measure gene expression.
- Immunoblotting will be used to measure protein expression
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2G3
- University of Alberta
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Written informed consent
- Age 18 through 80 years, inclusive
- Scheduled for heart surgery with CPB
Exclusion Criteria:
- Females of childbearing potential
- Emergency surgery
- Previous sternotomy
- Myocardial infarction within 48 hours prior to surgery
- Diabetes and/or BMI >35
- Need for Alpha2-agonists perioperatively
- Peripheral Vascular Disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ischemic Preconditioned Group (rIP)
A 15-cm sterile blood pressure cuff was placed around the right thigh and connected to the inflating device, and the patient was draped obscuring the visibility of the cuff.
Subsequently, the patient was randomly allocated (by opening of an envelope) to RIPC consisting of four 5-min cycles of lower limb ischemia-reperfusion induced by a tourniquet inflated to 300 mmHg
|
The blood pressure cuff will be inflated for 5 minutes and then deflated for 5 minutes.
This will be done 4 times in a row.
|
No Intervention: No Cuff
No rIP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Myocardial Protection Against Ischemic Injury
Time Frame: 72 hours post operatively
|
High-sensitivity cardiac troponin T release as measured by peak hscTnT values and area-under-the-curve.
|
72 hours post operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause Death and Cardiovascular Long-term Outcome
Time Frame: 6-month cardiovascular outcome
|
Death and re-hospitalization due to any cause including heart and renal failure and new atrial fibrillation
|
6-month cardiovascular outcome
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Barry A Finegan, MB, University of Alberta
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROTEcT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Remote Ischemic Preconditioning
-
Xuzhou Medical UniversityCompletedMyocardial Injury | Remote Ischemic PreconditioningChina
-
Seoul National University HospitalCompletedRemote Ischemic PreconditioningKorea, Republic of
-
Acibadem UniversityCompletedRemote Organ Ischemic PreconditioningTurkey
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingLiver Surgery | Remote Ischaemic PreconditioningItaly
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingMyocardial Injury | Remote Ischemic Preconditioning | Non-cardiac SurgeryChina
-
ISAR KlinikumActive, not recruitingOrthostatic Intolerance | Remote Ischemic Preconditioning | Hemodynamics | MicrocirculationGermany
-
Changi General HospitalUniversity College Hospital GalwayCompletedContrast Induced Nephropathy | Remote Ischaemic PreconditioningSingapore
-
Xuzhou Medical UniversityUnknownLung Injury | Remote Ischemic PreconditioningChina
-
The Affiliated Hospital of Xuzhou Medical UniversityUnknownBrain Injuries | Remote Ischemic PreconditioningChina
-
Mid Western Regional Hospital, IrelandCompletedContrast Induced Nephropathy | Remote Ischaemic PreconditioningIreland
Clinical Trials on Blood Pressure Cuff
-
Mayo ClinicCompletedCoronary Artery IschemiaUnited States
-
University Medicine GreifswaldWithdrawnIschemic Heart DiseaseGermany
-
Xim LimitedBarts & The London NHS Trust; Mind Over Matter Medtech Ltd; Health Innovation...Not yet recruiting
-
Johns Hopkins UniversityTerminatedAcute Myocardial InfarctionUnited States
-
St. Jude Children's Research HospitalCompleted
-
University of New England, AustraliaTerminated
-
Nemours Children's ClinicSuspended
-
University of North Carolina, Chapel HillCompletedHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Blood Pressure Disorders | Postpartum PreeclampsiaUnited States
-
Stanford UniversityNot yet recruitingCardiovascular Diseases | Hypertension | Blood Pressure
-
West Michigan Cancer CenterVeta HealthRecruiting